Subject: Immune Response Drops On News of Clinical Trials Delay
Date: Published: 3/9/92 (30 lines)
Source: Wall Street Journal. Copyright Dow Jones & Co. Inc.

    OTC Focus:
    Outcome of Kendall Square's Offering
    May Affect Many Computer Firms' Plans
    ----
    By Anne Newman
    Staff Reporter of The Wall Street Journal

    NEW YORK -- Computer-related companies already are going
 public in droves, but Kendall Square Research Corp. could
 boost the pace of technology offerings to a new level.  This
 unseasoned company, which has sold just three supercomputers,
 aims to go public within a month or so by selling stock that
 would value the company at 110 times last year's revenue.

[82 lines irrelevant to AIDS removed.  -- sysop]

    Immune Response dropped 1 3/4 to 26 3/4.  The company said
 clinical trials of its AIDS vaccine have been delayed because
 of product-liability concerns.  It didn't say how long it will
 postpone the study, under which 10 to 15 people, uninfected
 with acquired immune deficiency syndrome, will receive the
 vaccine.

[This article is made available here by Dow Jones Co. for the
 personal and non-commercial use of callers to this bbs, in the
 hope that it will be of some help to those who are suffering
 from the disease and others who are seeking to help them.]